AAM
TRIB

ACK Asset Management’s Trinity Biotech TRIB Stock Holding History

ACK Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-195,920
Closed -$12.9M – 39
2016
Q3 		$12.9M Hold
195,920
– – 3.93% 10
2016
Q2 		$11.1M Hold
195,920
– – 3.3% 11
2016
Q1 		$11.4M Sell
195,920
-4,080
-2% -$217K 4.49% 9
2015
Q4 		$11.8M Buy
200,000
+14,400
+8% +$850K 6.03% 6
2015
Q3 		$10.6M Buy
185,600
+6,000
+3% +$483K 4.44% 9
2015
Q2 		$16.2M Buy
179,600
+16,592
+10% +$1.44M 4.53% 7
2015
Q1 		$15.7M Buy
163,008
+24,920
+18% +$2.3M 4.96% 6
2014
Q4 		$12.1M Sell
138,088
-11,885
-8% -$1.02M 4.36% 7
2014
Q3 		$13.7M Buy
149,973
+13,042
+10% +$1.41M 4.92% 6
2014
Q2 		$15.8M Hold
136,931
– – 4.74% 6
2014
Q1 		$16.6M Buy
136,931
+1,071
+0.8% +$140K 5.46% 5
2013
Q4 		$17.1M Buy
135,860
+1,440
+1% +$173K 5.63% 6
2013
Q3 		$14.6M Buy
134,420
+3,000
+2% +$292K 5.62% 6
2013
Q2 		$11.1M Buy
+131,420
New +$10.9M 4.49% 7

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

ACK Asset Management's TRIB Position: Q4 2016 in Review

ACK Asset Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 195,920 shares — an estimated $12.9M sold.

ACK Asset Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $17.1M in Q4 2013. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • ACK Asset Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • ACK Asset Management sold 195,920 Trinity Biotech shares in Q4 2016, an estimated $12.9M.
  • ACK Asset Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • ACK Asset Management's Trinity Biotech position peaked at $17.1M in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on ACK Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.